TY - JOUR TI - Umbilical cord blood cells for the treatment of preterm white matter injury: Potential effects and treatment options AU - Qiu, Han AU - Qian, Tianyang AU - Wu, Tong AU - Wang, Xiaoyang AU - Zhu, Changlian AU - Chen, Chao AU - Wang, Laishuan T2 - Journal of Neuroscience Research AB - Preterm birth is a global public health problem. A large number of preterm infants survive with preterm white matter injury (PWMI), which leads to neurological deficits, and has multifaceted etiology, clinical course, monitoring, and outcomes. The principal upstream insults leading to PWMI initiation are hypoxia-ischemia and infection and/or inflammation and the key target cells are late oligodendrocyte precursor cells. Current PWMI treatments are mainly supportive, and thus have little effect in terms of protecting the immature brain or repairing injury to improve long-term outcomes. Umbilical cord blood (UCB) cells comprise abundant immunomodulatory and stem cells, which have the potential to reduce brain injury, mainly due to anti-inflammatory and immunomodulatory mechanisms, and also through their release of neurotrophic or growth factors to promote endogenous neurogenesis. In this review, we briefly summarize PWMI pathogenesis and pathophysiology, and the specific properties of different cell types in UCB. We further explore the potential mechanism by which UCB can be used to treat PWMI, and discuss the advantages of and potential issues related to UCB cell therapy. Finally, we suggest potential future studies of UCB cell therapy in preterm infants. DO - https://doi.org/10.1002/jnr.24751 DP - Wiley Online Library VL - n/a IS - n/a LA - en SN - 1097-4547 ST - Umbilical cord blood cells for the treatment of preterm white matter injury UR - https://onlinelibrary.wiley.com/doi/abs/10.1002/jnr.24751 Y2 - 2020/11/26/00:49:35 KW - brain injuries KW - cell transplantation KW - inflammation KW - mitochondria KW - oligodendrocyte precursor cells ER -